Immunomodulatory effects of polysaccharopeptide (PSP) in human PBMC through regulation of TRAF6/TLR immunosignal-transduction pathways

References

• Hyde, H.A., Adams, K.F. Airborne allegens at Cardiff, 1942–1959. Acta Allergol. 1960, 15, 159–169.
   Google Scholar
• Chu, K.K., Ho, S.S., Chow, A.H. Coriolus versicolor: a medicinal mushroom with promising immunotherapeutic values. J. Clin. Pharmacol. 2002, 42, 976–984.
   PubMed Web of Science ®Google Scholar
• Ng, T.B. A review of research on the protein-bound polysaccharide (polysaccharopeptide, PSP) from the mushroom Coriolus versicolor (Basidiomycetes: Polyporaceae). Gen. Pharmacol. 1998, 30, 1–4.
   PubMedGoogle Scholar
• Wang, H.X., NG, T.B., Liu, W.K., Ooi, V.E., Chang, S.T. Polysaccharide-peptide complexes from the cultured mycelia of the mushroom Coriolus versicolor and their culture medium activate mouse lymphocytes and macrophages. Int. J. Biochem. Cell Biol. 1996, 28, 601–607.
   PubMed Web of Science ®Google Scholar
• Zhou, X.W., Hua, J., Lin, J., Tang, K.X. Cytotoxic activities of Coriolus versicolor (Yunzhi) extracts on human liver cancer and breast cancer cell line. Afr. J. Biotechnol. 2007, 6, 1740–1743.
   Google Scholar
• Ohwada, S., Ogawa, T., Makita, F., et al. Beneficial effects of protein-bound polysaccharide K plus tegafur/uracil in patients with stage II or III colorectal cancer: analysis of immunological parameters. Oncol. Rep. 2006, 15, 861–868.
   PubMed Web of Science ®Google Scholar
• Yang, X., Sit, W.H., Chan, D.K., Wan, J.M. The cell death process of the anticancer agent polysaccharide-peptide (PSP) in human promyelocytic leukemic HL-60 cells. Oncol. Rep. 2005, 13, 1201–1210.
   PubMedGoogle Scholar
• Sherr, C.J., Roberts, J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999, 13, 1501–1512.
   PubMed Web of Science ®Google Scholar
• Li, J., Bao, Y., Lam, W., et al. Immunoregulatory and anti-tumor effects of polysaccharopeptide and Astragalus polysaccharides on tumor-bearing mice. Immunopharmacol. Immunotoxicol. 2008, 30, 771–782.
   PubMed Web of Science ®Google Scholar
• Mao, X.W., Archambeau, J.O., Gridley, D.S. Immunotherapy with low-dose interleukin-2 and a polysaccharopeptide derived from Coriolus versicolor. Cancer Biother. Radiopharm. 1996, 11, 393–403.
   PubMedGoogle Scholar
• Li, X.Y. Advances in immunomodulating studies of PSP. In: Yang, Q.Y. (ed.), Advanced Research in PSP. Hong Kong Association for Health Care Ltd., 1999, pp. 39–46.
   Google Scholar
• Bao, Y.X., Wong, C.K., Leung, S.F., et al. Clinical studies of immunomodulatory activities of Yunzhi-Danshen in patients with nasopharyngeal carcinoma. J. Altern. Complement. Med. 2006, 12, 771–776.
   PubMed Web of Science ®Google Scholar
• Han, S.B., Yoon, Y.D., Ahn, H.J., et al. Toll-like receptor-mediated activation of B cells and macrophages by polysaccharide isolated from cell culture of Acanthopanax senticosus. Int. Immunopharmacol. 2003, 3, 1301–1312.
   PubMed Web of Science ®Google Scholar
• Ando, I., Tsukumo, Y., Wakabayashi, T., et al. Safflower polysaccharides activate the transcription factor NF-kappa B via Toll-like receptor 4 and induce cytokine production by macrophages. Int. Immunopharmacol. 2002, 2, 1155–1162.
   PubMed Web of Science ®Google Scholar
• Yoon, Y.D., Han, S.B., Kang, J.S., et al. Toll-like receptor 4-dependent activation of macrophages by polysaccharide isolated from the radix of Platycodon grandiflorum. Int. Immunopharmacol. 2003, 3, 1873–1882.
   PubMed Web of Science ®Google Scholar
• Kawai, T., Akira, S. TLR signaling. Semin. Immunol. 2007, 19, 24–32.
   PubMed Web of Science ®Google Scholar
• Qian, Z.M., Xu, M.F., Tang, P.L. Polysaccharide peptide (PSP) restores immunosuppression induced by cyclophosphamide in rats. Am. J. Chin. Med. 1997, 25, 27–35.
   PubMedGoogle Scholar
• Liu, M., Ju, X., Willmarth, N.E., et al. Nuclear factor-kappaB enhances ErbB2-induced mammary tumorigenesis and neoangiogenesis in vivo. Am. J. Pathol. 2009, 174, 1910–1920.
   Google Scholar
• Wong, C.K., Bao, Y.X., Wong, E.L., Leung, P.C., Fung, K.P., Lam, C.W. Immunomodulatory activities of Yunzhi and Danshen in post-treatment breast cancer patients. Am. J. Chin. Med. 2005, 33, 381–395.
   PubMed Web of Science ®Google Scholar
• Tzianabos, A.O. Polysaccharide immunomodulators as therapeutic agents: structural aspects and biologic function. Clin. Microbiol. Rev. 2000, 13, 523–533.
   PubMed Web of Science ®Google Scholar
• Yang, J.C., Zhang, Y., Tian, J.D., Lu, J.S., Sheng, W.H. The stimulative and inductive effects of Coriolus versicolor polysaccharide-peptide (PSP) on interferon. In: Yang, Q.Y. (ed.). International Symposium on Traditional Chinese Medicine and Cancer: Development and Clinical Validation—Advanced Research in PSP. Hong Kong Association for Health Care Ltd., 1999, pp. 164–167.
   Google Scholar
• Zhong, Y., Zou, J., Zhang, L.Y. Clinical observation on alleviating chemotherapy’s side effect of PSP in treating gastric carcinoma. Liaoning J. Trad. Chinese Med. 2001, 28, 668–669.
   Google Scholar
• Akira, S., Uematsu, S., Takeuchi, O. Pathogen recognition and innate immunity. Cell. 2006, 124, 783–801.
   PubMed Web of Science ®Google Scholar
• Akira, S., Takeda, K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4, 499–511.
   PubMed Web of Science ®Google Scholar
• Tsang, K.W., Lam, C.L., Yan, C., et al. Coriolus versicolor polysaccharide peptide slows progression of advanced non-small cell lung cancer. Respir. Med. 2003, 97, 618–624.
   PubMed Web of Science ®Google Scholar